Evaluation of ARG protein expression in mature B cell lymphomas compared to non-neoplastic reactive lymph node

Cellular Immunology

Volumn 259, Issue 2, 2009, Pages 111-116

  Kabiri, Zahra ^a   Salehi, Mansoor ^a   Mokarian, Fariborz ^a   Mohajeri, Mohammad Reza ^b   Mahmoodi, Farzaneh ^b   Keyhanian, Kianoosh ^a   Doostan, Iman ^a   Ataollahi, Mohammad Reza ^a   Modarressi, Mohammad Hossein ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Pathology   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Abl 1; ABL 2; Abl Related Gene (ARG); Burkitt's Lymphoma (BL); c Abl; Diffused Large B Cell Lymphoma (DLBCL); Follicular Lymphoma (FL)

Indexed keywords

ABELSON KINASE; ABELSON KINASE RELATED PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; PROTEIN ARG; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER STAGING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BURKITT LYMPHOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; NEOPLASM STAGING; PROTEIN-TYROSINE KINASES;

EID: 70349115181     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.06.004     Document Type: Article

References (54)

1. Shaffer A.L., Rosenwald A., and Staudt L.M. Lymphoid malignancies: the dark side of B-cell differentiation. Nat. Rev. Immunol. 2 12 (2002) 920-932
2. Margrath L.T., Venkatesh H., and Gascoyne R.D. Burkitt's lymphoma. In: Mauch P.M., Armitage J.O., Coiffier B., Dalla-Favera R., and Lee Harris N. (Eds). Non-Hodgkin Lymphoma (2004), Lippincott Wiliams and Wilkins Publication 477
3. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., Powell J.I., Yang L., Marti G.E., Moore T., Hudson J., Lu L., Lewis D.B., Tibshirani R., Sherlock G., Chan W.C., Greiner T.C., Weisenburger D.D., Armitage J.O., Warnke R., Levy R., Wilson W., Grever M.R., Byrd J.C., Botstein D., Brown P.O., and Staudt L.M. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 6769 (2000) 503-511
4. Groves F.D., Linet M.S., Travis L.B., and Devesa S.S. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J. Natl. Cancer. Inst. 92 15 (2000) 1240-1251
5. Anderson J.R., Vose J.M., Bierman P.J., Weisenberger D.D., Sanger W.G., Pierson J., Bast M., and Armitage J.O. Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group. J. Clin. Oncol. 11 2 (1993) 218-224
6. Rodriguez J., McLaughlin P., Hagemeister F.B., Fayad L., Rodriguez M.A., Santiago M., Hess M., Romaguera J., and Cabanillas F. Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features. Blood 93 7 (1999) 2202-2207
7. Pawson T. Non-catalytic domains of cytoplasmic protein-tyrosine kinases: regulatory elements in signal transduction. Oncogene 3 5 (1988) 491-495
8. Kruh G.D., Perego R., Miki T., and Aaronson S.A. The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc. Natl. Acad. Sci. USA 87 15 (1990) 5802-5806
9. Daley G.Q., Van Etten R.A., and Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247 4944 (1990) 824-830
10. Heisterkamp N., Jenster G., Ten Hoeve J., Zovich D., Pattengale P.K., and Groffen J. Acute leukaemia in bcr/abl transgenic mice. Nature 344 6263 (1990) 251-253
11. Chen W.S., Kung H.J., Yang W.K., and Lin W. Comparative tyrosine-kinase profiles in colorectal cancers: enhanced arg expression in carcinoma as compared with adenoma and normal mucosa. Int. J. Cancer 83 5 (1999) 579-584
12. Iijima Y., Ito T., Oikawa T., Eguchi M., Eguchi-Ishimae M., Kamada N., Kishi K., Asano S., Sakaki Y., and Sato Y. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation. Blood 95 6 (2000) 2126-2131
13. Liu L.X., Liu Z.H., Jiang H.C., Qu X., Zhang W.H., Wu L.F., Zhu A.L., Wang X.Q., and Wu M. Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array. World J. Gastroenterol. 8 4 (2002) 580-585
14. Liu L.X., Liu Z.H., Jiang H.C., Zhang W.H., Qi S.Y., Hu J., Wang X.Q., and Wu M. Gene expression profiles of hepatoma cell line HLE. World J. Gastroenterol. 9 (2003) 683-687
15. Liu L.X., Jiang H.C., Liu Z.H., Zhu A.L., Zhou J., Zhang W.H., Wang X.Q., and Wu M. Gene expression profiles of hepatoma cell line BEL-7402. Hepatogastroenterology 50 (2003) 1496-1501
16. Lu T.J., Lu T.L., Su I.J., and Lai M.D. Tyrosine kinase expression profile in bladder cancer. Anticancer. Res. 17 (1997) 2635-2637
17. Meric F., Lee W.P., Sahin A., Zhang H., Kung H.J., and Hung M.C. Expression profile of tyrosine kinases in breast cancer. Clin. Cancer Res. 8 (2002) 361-367
18. Ivan D., Niveiro M., Diwan A.H., Eton O., Kim K.B., Lacey C., Gonzalez C., and Prieto V.G. Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec). J. Cutan. Pathol. 33 4 (2006) 280-285
19. de Vos S., Hofmann W.K., Grogan T.M., Krug U., Schrage M., Miller T.P., Braun J.G., Wachsman W., Koeffler H.P., and Said J.W. Gene expression profile of serial samples of transformed B-cell lymphomas. Lab. Invest. 83 2 (2003) 271-285
20. Van Etten R.A., Jackson P.K., Baltimore D., Sanders M.C., Matsudaira P.T., and Janmey P.A. The COOH terminus of the c-Abl tyrosine kinase contains distinct F- and G-actin binding domains with bundling activity. J. Cell Biol. 124 3 (1994) 325-340
21. Wang B., and Kruh G.D. Subcellular localization of the Arg protein tyrosine kinase. Oncogene 13 1 (1996) 193-197
22. Koleske A.J., Gifford A.M., Scott M.L., Nee M., Bronson R.T., Miczek K.A., and Baltimore D. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron 21 6 (1998) 1259-1272
23. Li Y., Shimizu H., Xiang S.L., Maru Y., Takao N., and Yamamoto K. Arg tyrosine kinase is involved in homologous recombinational DNA repair. Biochem. Biophys. Res. Commun. 299 5 (2002) 697-702
24. Sawyers C.L., McLaughlin J., Goga A., Havlik M., and Witte O. The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 77 1 (1994) 121-131
25. Yuan Z.M., Huang Y., Ishiko T., Kharbanda S., Weichselbaum R., and Kufe D. Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc. Natl. Acad. Sci. USA 94 4 (1997) 1437-1440
26. Yuan Z.M., Shioya H., Ishiko T., Sun X., Gu J., Huang Y.Y., Lu H., Kharbanda S., Weichselbaum R., and Kufe D. P73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature 399 6738 (1999) 814-817
27. Yuan Z.M., Huang Y., Ishiko T., Nakada S., Utsugisawa T., Kharbanda S., Wang R., Sung P., Shinohara A., Weichselbaum R., and Kufe D. Regulation of Rad51 function by c-Abl in response to DNA damage. J. Biol. Chem. 273 7 (1998) 3799-3802
28. Chen G., Yuan S.S., Liu W., Xu Y., Trujillo K., Song B., Cong F., Goff S.P., Wu Y., Arlinghaus R., Baltimore D., Gasser P.J., Park M.S., Sung P., and Lee E.Y. Radiation-induced assembly of Rad51 and Rad52 recombination complex requires ATM and c-Abl. J. Biol. Chem. 274 18 (1999) 12748-12752
29. Shinohara A., and Ogawa T. Homologous recombination and the roles of double-strand breaks. Trends. Biochem. Sci. 20 10 (1995) 387-391
30. Sonoda E., Sasaki M.S., Buerstedde J.M., Bezzubova O., Shinohara A., Ogawa H., Takata M., Yamaguchi-Iwai Y., and Takeda S. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17 2 (1998) 598-608
31. Pendergast A.M. The Abl family kinases: mechanisms of regulation and signaling. Adv. Cancer Res. 85 (2002) 51-100
32. Cao C., Leng Y., Li C., and Kufe D. Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response. J. Biol. Chem. 278 15 (2003) 12961-12967
33. Galkin V.E., Orlova A., Koleske A.J., and Egelman E.H. The Arg non-receptor tyrosine kinase modifies F-actin structure. J. Mol. Biol. 346 2 (2005) 565-575
34. Okuda K., Weisberg E., Gilliland D.G., and Griffin J.D. ARG tyrosine kinase activity is inhibited by STI571. Blood 97 8 (2001) 2440-2448
35. Hardin J.D., Boast S., Schwartzberg P.L., Lee G., Alt F.W., Stall A.M., and Goff S.P. Bone marrow B lymphocyte development in c-Abl-deficient mice. Cell. Immunol. 165 (1995) 44-54
36. Hardin J.D., Boast S., Schwartzberg P.L., Lee G., Alt F.W., Stall A.M., and Goff S.P. Abnormal peripheral lymphocyte function in c-Abl mutant mice. Cell. Immunol. 172 (1996) 100-107
37. Bianchi C., Muradore I., Corizzato M., Cornacchini G., Beretta L., Erba E., Del Monte U., and Perego A.R. The expression of the non-receptor tyrosine kinases Arg and c-Abl is differently modulated in B lymphoid cells at different stages of differentiation. FEBS Lett. 527 1-3 (2002) 216-222
38. Rosenberg S.A. Validity of the Ann Arbor staging classification for the non-Hodgkin's lymphomas. Cancer Treat. Rep. 61 6 (1977) 1023-1027
39. Salehi M., Barron M., Merry B.J., and Goyns M.H. Fluorescence in situ hybridization analysis of the fos/jun ratio in the ageing brain. Mech. Ageing Dev. 107 1 (1999) 61-71
40. Finnegan M.C., Goepel J.R., Hancock B.W., and Goyns M.H. Investigation of the expression of housekeeping genes in non-Hodgkin's lymphoma. Leuk. Lymphoma 10 4-5 (1993) 387-393
41. Isakov N., and Biesinger B. Lck protein tyrosine kinase is a key regulator of T-cell activation and a target for signal intervention by Herpesvirus saimiri and other viral gene products. Eur. J. Biochem. 267 12 (2000) 3413-3421
42. Kain K.H., and Klemke R.L. Inhibition of cell migration by Abl family tyrosine kinases through uncoupling of Crk-CAS complexes. J. Biol. Chem. 276 19 (2001) 16185-16192
43. MacLeod R.A.F., Nagel S., Scherr M., Schneider B., Dirks W.G., Uphoff C.C., Quentmeier H., and Drexler H.G. Human leukemia and lymphoma cell lines as models and resources. Curr. Med. Chem. 15 4 (2008) 339-359
44. Perego R.A., Corizzato M., Bianchi C., Eroini B., and Bosari S. N- and C-terminal isoforms of Arg quantified by real-time PCR are specifically expressed in human normal and neoplastic cells, in neoplastic cell lines, and in HL-60 cell differentiation. Mol. Carcinogen. 42 (2005) 229-239
45. Sigal S., Ninette A., and Rechavi G. Microarray studies of prognostic stratification and transformation of follicular lymphomas. Best Pract. Res. Cl. Ha. 18 1 (2005) 143-156
46. M. Salehi, Z. Kabiri, F. Mokarian, I. Doostan, M.R. Ataollahi, M.R. Nooridaloii, Study of ARG (ABL related gene-ABL2) protein, a tyrosine kinase protein, in Burkitt's lymphoma, J. Sci., Islamic Republic of Iran 18(3) (2007) 215-220.
47. Yang C., Lu P., Lee F.Y., Chadburn A., Barrientos J.C., Leonard J.P., Ye F., Zhang D., Knowles D.M., and Wang Y.L. Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinib. Leukemia 22 (2008) 1755-1766
48. Crnogorac-Jurcevic T., Efthimiou E., Nielsen T., Loader J., Terris B., Stamp G., Baron A., Scarpa A., and Lemoine N.R. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 21 29 (2002) 4587-4594
49. Wu C.W., Li A.F., Chi C.W., Huang C.J., Huang C.L., Lui W.Y., and Lin W.C. Arg tyrosine kinase expression in human gastric adenocarcinoma is associated with vessel invasion. Anticancer Res. 23 1A (2003) 205-210
50. Sasaki H., Ide N., Yukiue H., Kobayashi Y., Fukai I., Yamakawa Y., and Fujii Y. Arg and DAP3 expression was correlated with human thymoma stage. Clin. Exp. Metastasis 21 6 (2004) 507-513
51. Plattner R., Kadlec L., DeMali K.A., Kazlauskas A., and Pendergast A.M. C-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF. Genes Dev. 13 (1999) 2400-2411
52. Cao C., Ren X., Kharbanda S., Koleske A., Prasad K.V.S., and Kufe D. The ARG tyrosine kinase interacts with Siva-1 in the apoptotic response to oxidative stress. J. Biol. Chem. 276 15 (2001) 11465-11468
53. Appel S., Balabanov S., Brümmendorf T.H., and Brossart P. Effects of imatinib on normal hematopoiesis and immune activation. Stem Cells 23 8 (2005) 1082-1088
54. Deininger M. Tyrosine kinase inhibitors. In: Gewirtz D.A., Holt S.E., and Grant S. (Eds). Cancer Drug Discovery and Development, Apoptosis, Senescence, and Cancer (2007), Humana Press Inc., Totowa 477-508